Shrier Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Shrier Wealth Management's NVS Position: Q3 2026 in Review
Shrier Wealth Management reduced its Novartis (NVS) stake by 0.57% in Q3 2026, selling an estimated $20.5K and leaving 23,749 shares worth $3.39M. The position accounts for 1.14% of the portfolio, ranked #25.
Shrier Wealth Management first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.74M in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Shrier Wealth Management held 23,749 shares of Novartis worth $3.39M as of Q3 2026.
- Shrier Wealth Management sold 135 Novartis shares in Q3 2026, an estimated $20.5K.
- Novartis made up 1.14% of Shrier Wealth Management's portfolio in Q3 2026, its #25 holding.
- Shrier Wealth Management first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
- Shrier Wealth Management's Novartis position peaked at $3.74M in Q2 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Shrier Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.